Phase 4 Stomach Cancer Trial, Recruiting NCT02047994 Sponsor: International Agency for Research on Cancer Condition: Stomach Cancer
Back to Stomach Cancer

Phase 4 Stomach Cancer Trial, Recruiting

NCT02047994
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 40 and 64 years old at the time of signing the consent form
  • People who are willing to take part in the study regardless of which group they are assigned to, after being fully informed about the possible benefits and risks
  • People who have signed the consent form, including agreeing to have their samples transported across borders if needed
  • People who are in good general health, as confirmed by a physical examination and medical history review carried out by a study doctor at the time of joining

Who may not be able to join:

  • People with a personal history of stomach cancer (note: cases of stomach cancer not yet known at the time of joining will still be included)
  • People who have had part of their stomach surgically removed due to a non-cancerous condition (certain smaller procedures such as ulcer repair and vagotomy are accepted)
  • People who have received treatment to clear a stomach bacteria infection called H. pylori within the 12 months before joining, regardless of whether the treatment worked
  • People who have warning signs or symptoms related to digestive or other health problems, as identified through a questionnaire or during the doctor's assessment
  • People whose physical examination reveals findings that suggest a serious underlying illness, as determined by the study doctor
  • People with a serious ongoing health condition where life expectancy is estimated to be less than 5 years, as determined by the study doctor
  • People who have other factors that would limit their ability to follow the study requirements, such as problems with mobility
  • People with serious psychological or psychiatric conditions that limit their ability to understand what is required during testing or medical procedures, as determined by the study doctor
  • People who, in the study doctor's assessment, are unlikely to follow through with the required tests or treatments
  • People who are expected to be unavailable for follow-up, for example due to lack of communication access, inability to have data recorded in registries, or planned extended travel abroad, as determined by the study doctor
  • People who have not signed a consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Marcis Leja, MD, PhD, Professor, Institute of Clinical and Preventive Medicine, University of Latvia

Phone: +37 1 29 49 75 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
International Agency for Research on Cancer
Registry
ClinicalTrials.gov
Start date
1 March 2013
Est. completion
1 December 2033

Where this trial is recruiting

🇱🇻 Latvia

Primary endpoints

Gastric cancer mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov